If you've spent any time researching weight loss or metabolic health in the last few years, you've heard the name Tirzepatide. It's one of the most-studied medications to come out of endocrinology in a decade, and also one of the most misunderstood. Here's what it actually is, who it tends to help, and why we start every conversation about it with a consultation rather than a prescription.
What Tirzepatide Actually Does
Tirzepatide is a dual GIP/GLP-1 receptor agonist (a mouthful that means it mimics two hormones your gut already makes after you eat: GIP and GLP-1). Together, these hormones tell your pancreas to release insulin when blood sugar is high, slow down digestion so you feel full longer, and signal your brain that you've had enough to eat. Because insulin release is glucose-dependent, it only kicks in when your blood sugar is actually elevated, which is a big part of why the medication carries a low risk of hypoglycemia on its own.
Under the brand names Mounjaro (approved for type 2 diabetes) and Zepbound (approved for chronic weight management), tirzepatide has posted some of the strongest clinical trial results we've seen in this category. In the SURMOUNT-1 trial, adults with obesity who didn't have diabetes lost an average of 22.5% of their body weight over 72 weeks at the highest studied dose, meaningfully more than earlier-generation GLP-1 medications in head-to-head comparisons.
Brand-Name vs. Compounded: An Honest Comparison
This is the part most articles gloss over, so we won't.
Mounjaro and Zepbound are FDA-approved. That means Eli Lilly's manufacturing, dosing accuracy, and safety data have gone through the FDA's full review process. Compounded tirzepatide (tirzepatide prepared by a licensed 503A pharmacy rather than manufactured by Lilly) is not FDA-approved, and its legal availability has narrowed significantly. As of 2026, compounding pharmacies can only prepare tirzepatide for a specific patient when there's a documented clinical reason the FDA-approved product won't work for them (for example, a verified allergy to an inactive ingredient), not simply for cost or convenience.
We think that's worth knowing upfront, because it shapes how we approach every consultation: the FDA-approved product is our starting point, and compounding is discussed only when there's a genuine clinical basis for it. Anyone offering compounded tirzepatide as an open, no-questions-asked menu item isn't practicing within current guidelines, and that's not how we operate.
Who Tends to Benefit
Tirzepatide isn't a fit for everyone, and it isn't a substitute for the basics: nutrition, movement, sleep, and stress management still matter enormously. That said, people who often see meaningful benefit include those who:
- Have a BMI of 30+ (obesity), or 27+ with a weight-related condition like high blood pressure, high cholesterol, sleep apnea, or prediabetes
- Have type 2 diabetes and are working with their provider on glycemic control
- Have tried diet and exercise interventions without the results they were hoping for
- Don't have a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome (both are contraindications)
- Are prepared for the lifestyle piece: protein intake, hydration, and strength training all meaningfully affect how well the medication works and how you feel on it
None of this is something you can accurately self-assess from a blog post (including this one). It's exactly why we don't sell tirzepatide off a price list: we start with a conversation.
Common Side Effects
The most frequently reported side effects are gastrointestinal: nausea, diarrhea, constipation, and abdominal discomfort, especially during dose increases. These are usually manageable with slower titration, dietary adjustments, and staying ahead of hydration. Less common but more serious risks include gallstones, pancreatitis, and low blood sugar when combined with other diabetes medications, which is exactly why ongoing follow-up with a provider matters, not just an initial prescription.
Why We Start With a Consultation
Every new client interested in Tirzepatide, or any of our peptide and metabolic therapies, starts with a consultation, not an order form. During that visit, we review your health history, current medications, lab work (or get it drawn if it's been a while), and your goals, and talk honestly about whether an FDA-approved product, a different approach entirely, or, in narrow, clinically appropriate cases, a compounded option makes sense for you.
This isn't extra red tape. It's the difference between a medication that's monitored and adjusted by someone who knows your history, and a medication you're managing alone based on a dosage chart.
New Client Wellness Consultation: $199
Standard follow-up / weight-loss / peptide consultation: $50
If you've been curious about Tirzepatide and want a straight answer about whether it's right for you, book a consultation and let's talk through it together.